Clinical news updates from the 2008 American Heart Association Scientific Sessions; Preferential formulary listing of a proton-pump inhibitor; Drug Watch: Agents in late-stage development for the treatment of multiple sclerosis

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Formulary Digital Edition December 2008

Newsletter